Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Growth hormones with prolonged in-vivo efficacy

Growth hormones with prolonged in-vivo efficacy

US Patent 8779109 · Granted Jul 15, 2014

Estimated economic value: $38,478,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Glucose-sensitive albumin-binding derivatives2025
Glucose-sensitive albumin-binding derivatives2023
Protein conjugates2022
Glucose-sensitive albumin-binding derivatives2021
Factor VII conjugates2019
GLP-1 compounds2018
Antagonistic DR3 ligands2017
Antagonistic DR3 ligands2017
Growth hormones with prolonged in-vivo efficacy2017
Growth hormones with prolonged in-vivo efficacy2017
Growth hormones with prolonged in-vivo efficacy2017
Growth hormones with prolonged in-vivo efficacy2017